[phil]

I want to correct some info I gave above. we advocated for L. to get the drug if plats were below 75,000 but above 50,000.
I would argue for more time to observe that nodule , continuing to get drug, and if the drug has been appr. by your Board in England then I hope your doc can continue to give it , even if you leave the trial . I don't kow why your mothers docs are talking about " end of the road " . some pts have stopped it here for s/e and still continued to benefit. they continue on combos like Herceptin/ navelbine or Herceptin / tykerb. it seems as if t dm-1 weakened the cancer and these less strong combos seem more effective as a result. pts here are saying adding perjeta to t dm-1 increases its effectiveness. I don't know if its available there.